Empresa Immunoprecise Antibodies Ltd Toronto S.E.
Acciones
TQY
CA87588T2020
Farmacéuticos
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody Production Project
90,4
%
| 14 | 89,6 % | 14 | 90,4 % | +1,56 % |
Antibody Production Product
8,5
%
| 1 | 8,5 % | 1 | 8,5 % | -0,20 % |
Cryostorage
1,2
%
| 0 | 1,8 % | 0 | 1,2 % | -36,11 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Europe
45,7
%
| 8 | 48,7 % | 7 | 45,7 % | -5,42 % |
United States
45,3
%
| 5 | 35,2 % | 7 | 45,3 % | +29,67 % |
Australia
3,0
%
| 1 | 8,0 % | 0 | 3,0 % | -61,39 % |
Canada
3,0
%
| 0 | 3,0 % | 0 | 3,0 % | +1,96 % |
Other
2,9
%
| 1 | 5,2 % | 0 | 2,9 % | -43,58 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jennifer Bath
CEO | Chief Executive Officer | - | 21/02/18 |
Kristin Taylor
DFI | Director of Finance/CFO | - | 29/09/23 |
Ilse Roodink
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/21 |
Frederick Chabot
IRC | Investor Relations Contact | - | - |
Barry Duplantis
PRN | Corporate Officer/Principal | - | - |
Kari Graber
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mitchell Levine
CHM | Chairman | - | - |
Chris Buyse
BRD | Director/Board Member | 59 | 05/09/23 |
Jennifer Bath
CEO | Chief Executive Officer | - | 21/02/18 |
Dirk Witters
BRD | Director/Board Member | - | 05/09/23 |
Barry Springer
BRD | Director/Board Member | - | 05/09/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 26 315 260 | 22 738 411 ( 86,41 %) | 0 | 86,41 % |
Información de la empresa
ImmunoPrecise Antibodies Ltd.
4464 Markham Street Suite 3204
V8Z 7X8, Victoria
+250-483-0308
http://www.immunoprecise.comVentas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,37 % | 89,37 mil M | |
+2,76 % | 40,65 mil M | |
-12,32 % | 32,81 mil M | |
+52,41 % | 25 mil M | |
-17,39 % | 15,29 mil M | |
-42,45 % | 11,61 mil M | |
-10,48 % | 11,49 mil M | |
+6,14 % | 8981,89 M | |
-7,72 % | 8226,73 M |